Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RILEXINE CHEWABLE TABLETS - Health Canada Drug Approval Details

Approvals/Health Canada/RILEXINE CHEWABLE TABLETS

Authorized

STANDARD

RILEXINE CHEWABLE TABLETS

VIRBAC AH, INC.🇨🇦 Health Canada

Approval Date: Feb 5, 2026
Approval ID: 3fc783ccba6a68ca
Company: VIRBAC AH, INC.
Type: Standard

Approval Details

Approval Id: 3fc783ccba6a68ca
Drug Approval Canada Name: RILEXINE CHEWABLE TABLETS
Product Name: RILEXINE CHEWABLE TABLETS
Status: Marketed
Status Date: 2022-02-23
Original Market Date: 2022-02-23
Din: 02442701
Drug Class: Veterinary
Dosage Form: Tablet (Chewable)
Route Of Administration: Oral
Schedule: Prescription
Atc Original: Not Applicable
Aig Number: 0105911007
Company Name: VIRBAC AH, INC.
Company Address: Po Box/Cp 162059 Fort Worth Texas United States 76161

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Feb 5, 2026

Approval ID

3fc783ccba6a68ca

Type

Standard

Back to Health Canada Approvals